Figure 2.
Risk reduction of the hospitalization for heart failure at 6 months after the start of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in randomized controlled trials (RCTs) which included non-diabetic patients or not.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.